Hit enter to search or ESC to close
Enterprise Analysis CorporationEnterprise Analysis Corporation
  • Who We Are
  • How We Work
  • Insights
  • Contact
Who Are We

About EAC

Who Are We

About EAC

Healthcare consulting with a difference

Our mission is helping diagnostics and life science companies commercialize tests and technologies that positively impact healthcare.

Our strategic consulting and market research services are designed to provide the data and insights that companies need to fully understand an opportunity, navigate through resource decisions, and successfully commercialize new solutions.

Questions We Answer

Methodologies We Use

Our Expertise
Our Experience
Our Global Partners
Our Leadership

Industry expertise that is
broad and deep

We know the disciplines of diagnostics and we know the technologies. Instruments or assays, established technology or innovation, centralized locations or near patient applications, we have the expertise to help and the insight to understand the relevance.

Clinical Medicine
Clinical Medicine
  • Infectious disease
  • Sepsis
  • Cancer
  • Autoimmune
  • Cardiovascular
  • Diabetes
  • Surgery
  • Trauma
  • Microbiome
Diagnostics
Diagnostic Disciplines
  • Molecular
  • Microbiology
  • Hematology
  • Clinical Chemistry
  • Immunoassay
  • Urinalysis
  • Hemostasis
  • Anatomic Pathology
  • Automation/Informatics
Technologies
Technologies
  • PCR/Nucleic Acid Amplification
  • Next Generation Sequencing
  • Flow Cytometry
  • Mass Spectrometry
  • Tissue Diagnostics
  • In-situ Hybridization
  • Microfluidics
  • Immunochromatography
  • Digital Morphology

Industry expertise that is broad and deep

We know the disciplines of diagnostics and we know the technologies. Instruments or assays, established technology or innovation, centralized locations or near patient applications, we have the expertise to help and the insight to understand the relevance.

  • Clinical Medicine
  • Diagnostic Disciplines
  • Technologies
  • Infectious disease
  • Sepsis
  • Cancer
  • Autoimmune
  • Cardiovascular
  • Diabetes
  • Surgery
  • Trauma
  • Microbiome
  • Molecular
  • Microbiology
  • Hematology
  • Clinical Chemistry
  • Immunoassay
  • Urinalysis
  • Hemostasis
  • Anatomic Pathology
  • Automation/Informatics
  • PCR/Nucleic Acid Amplification
  • Next Generation Sequencing
  • Flow Cytometry
  • Mass Spectrometry
  • Tissue Diagnostics
  • In-situ Hybridization
  • Microfluidics
  • Immunochromatography
  • Digital Morphology

Our Experience

30

Years of Global Experience

1400

Projects Assisted

160

Client Partners
Efficient & Accurate

Our clients tell us we are fast, nimble, and easy to work with. We know their language and their environment. Our clients get the results they expect.

Confidence

In our 30+ years of operation, we have delivered over 1400 projects to 160 client companies serving the US, Europe, Japan, China, Brazil, and other markets of the world.

Impactful

By bringing diagnostic companies closer to the market, we help clients make better product development and go-to-market decisions.

Our Global Partner Network

EAC’s network of research partners, consultants and advisors extends across North America, Europe, Latin America and Asia Pacific. Whether you need answers in select countries or you need a broader global perspective, our reach supports projects within and across your key geographies.

Our Leadership

Emery Stephans

Emery J. Stephans

Founder and CEO

Emery is the Founder and Chief Executive Officer of EAC.

Prior to EAC, Emery had a 26-year career at IBM in various research, development, manufacturing, and product management positions. This included seven years in IBM’s Biomedical Systems business unit and two years on special assignment at the New York Hospital-Cornell Medical Center on a project to reverse atherosclerosis by means of extracorporeal depletion of circulatory LDL.

Emery chaired the Industrial Liaison Committee of the American Association of Clinical Chemistry (AACC) POCT division, is a past chair of the NCCLS Subcommittee on Data Management and assisted in setting up a standardization effort for middleware data integration.

Emery specializes in corporate strategy development, portfolio and pipeline evaluation, and partnerships in life science and clinical medicine. Since 2012, he has been engaged in large clinical retrospective outcome studies in hospital acquired infections, Sepsis, and multi-drug resistant infectious organisms.

He holds a BS and MS in Physics from the South Dakota School of Mines & Technology, as well as a Private Pilot license with Instrument, Glider, and Seaplane ratings.

Troy Galloway

Troy Galloway

President

Troy is a 30+ year veteran of the diagnostics industry. She started her career as a laboratory technologist and then moved to the corporate environment, where she has had senior positions with leading manufacturers, including BD, Siemens, and Beckman Coulter.

Troy brings to EAC her breadth of experience in global marketing, strategy development and business management along with a broad knowledge of the IVD industry and products. She understands how companies approach decision-making and the kinds of insights needed to successfully develop, design, and commercialize new technologies.

Since joining EAC in 2016, Troy has leveraged her expertise to assist clients with product development and pricing strategies, outcome assessments, acquisitions, head-to-head performance studies and market segmentation.

Troy has a BS in Medical Technology from the University at Albany and a MS in Business from Johns Hopkins University Carey Business School.

Michelle Keane

Michelle Keane

Vice President, Operations

Michelle has 20 years of experience developing and managing global research studies for clients in the diagnostics industry. Her research program designs and execution have provided critical input toward the development of new products, the enhancement of existing products, establishment of appropriate pricing structures, and brand positioning. She has organized respondent panels to collect feedback over time for product development studies and has set up systems to monitor customer satisfaction and retention rates.

Most recently, Michelle has mined extensive patient data sets to support product development and market sizing, locate hot spots of infection in hospitals and triangulate points of deterioration in patient’s health during hospital stays. She is skilled in mathematical and statistical analysis, database design and management, as well as conducting in-person interviews, moderating focus groups and developing web-based surveys.

Michelle’s areas of expertise include infection prevention, healthcare associated infections, sepsis diagnostics, infectious disease and diagnostic testing in the core lab and at the point-of-care (POC). Further, she managed and published EAC’s multi-client quantitative reports on POC testing and US based Physician Office study. Michelle received her BS from Fordham University and her MBA from Mercy College, both in New York.

Mark Hughes

Mark Hughes

Vice President

Mark Hughes began his career in clinical research at the Harvard School of Public Health and progressed into immunoassay research and development for Dade Behring’s former Clinical Assay division. He has held management positions in market research and business planning at the Ares-Serono Group and Gene-Trak Systems.

Mark has more than 30 years of experience in the clinical diagnostics industry and has been with EAC since 1997. He has broad experience in characterization of in vitro diagnostic (IVD) and non-IVD market and product segments. He also has done extensive work in technology assessments, market analysis, business strategies and due diligence.

Mark has worked on a wide range of assignments for major diagnostic, pharmaceutical and start-up biotechnology companies, as well as investment banks and venture capital firms. He is often quoted in many industry publications for his insights into the IVD industry.

Mark received his BS from the University of Massachusetts at Amherst and his MBA from Duke University.

Get started on your custom solution today

Call UsContact Us
EAC Logo

Our mission is helping diagnostics and life science companies commercialize tests and technologies that positively impact healthcare.

Explore

  • Who We Are
  • How We Work
  • Insights
  • Contact

Contact

2777 Summer Street
Stamford, Connecticut 06905

  203-348-7001

  Send A Message  »

© 2023 Enterprise Analysis Corporation. All Rights Reserved.

  • Who We Are
  • How We Work
  • Insights
  • Contact

2777 Summer Street Stamford, Connecticut 06905

  203-348-7001

  Send A Message  »

    To view our flyer, please leave us your contact information:

    Note: Please make sure your browser accepts pop-ups for our website. You may have to manually accept pop-ups after clicking “View Article.”

      To view our article, please leave us your contact information:

      Note: Please make sure your browser accepts pop-ups for our website. You may have to manually accept pop-ups after clicking “View Article.”

        To view our article, please leave us your contact information:

        Note: Please make sure your browser accepts pop-ups for our website. You may have to manually accept pop-ups after clicking “View Article.”

          To view our article, please leave us your contact information:

          Note: Please make sure your browser accepts pop-ups for our website. You may have to manually accept pop-ups after clicking “View Article.”

            To view our article, please leave us your contact information:

            Note: Please make sure your browser accepts pop-ups for our website. You may have to manually accept pop-ups after clicking “View Article.”

              To view our article, please leave us your contact information:

              Note: Please make sure your browser accepts pop-ups for our website. You may have to manually accept pop-ups after clicking “View Article.”

                To view our article, please leave us your contact information:

                Note: Please make sure your browser accepts pop-ups for our website. You may have to manually accept pop-ups after clicking “View Article.”

                  To view our article, please leave us your contact information:

                  Note: Please make sure your browser accepts pop-ups for our website. You may have to manually accept pop-ups after clicking “View Article.”

                    To view our article, please leave us your contact information:

                    Note: Please make sure your browser accepts pop-ups for our website. You may have to manually accept pop-ups after clicking “View Article.”